Stock Mumak

Stock Profile

AstraZeneca

AstraZeneca is one of the world's leading pharmaceutical companies. Growth, strong cash flows, and an innovative drug pipeline support long-term prospects.

Stock Snapshot

Table Header Table Header
Company
Sector
Theme
Business Model
ISIN
Market Capitalization
UMBRELLA Status

Price Performance (12 Months)

Kein gueltiges Aktienkuerzel gefunden. Bitte ACF-Feld oder manuelle Werte pruefen.

Aktuelle Unternehmensmeldungen

Latest Portfolio Updates

MUMAK SpotLight

MUMAK SpotLight of the week: Portfolio rotation strengthens technology weighting

More Intel and Micron, exit from Rheinmetall and TKMS: The UMBRELLA Strategy is clearly shifting its focus toward technology.
Next Update
RED HOT CHILI™ MUMAK

RED HOT CHILI™ MUMAK of the Week: Intel – AI momentum is gaining momentum

Intel is the RED HOT CHILI MUMAK™ of the week: Renewed enthusiasm for AI infrastructure, improved sentiment in the semiconductor
Next Update
Weekly Update

Weekly Market Overview – September 14-September 20, 2026

UMBRELLA Strategy: Technology weighting expanded following portfolio adjustments.
Next Update
MUMAK SpotLight

MUMAK SpotLight of the week: Intel becomes part of the UMBRELLA Strategy

Intel was newly added to the UMBRELLA Strategy, expanding the portfolio's semiconductor positioning. At the same time, Revolution Medicines, Bayer,
Next Update